Personal information

Emails & domains

Verified email domains

Other IDs

ResearcherID: B-5366-2016
SciProfiles: 1902095

Activities

Collapse all

Works (30)

Simplified acid extraction and quantification of histones in human tumor cells

Methods in Cell Biology
2025 | Book chapter
DOI: 10.1016/bs.mcb.2024.10.002
Part of ISBN: 9780443296208
Part of ISSN: 0091-679X
Contributors: Lourdes Hontecillas-Prieto; Daniel J. García-Domínguez; Rocío Flores-Campos; Juan Antonio Flores; Antonio Pérez-Pérez; Luis de la Cruz-Merino; Víctor Sánchez-Margalet; Nabil Hajji
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Obesity and overweight in R/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8 + cells and vitamin D

Cancer & Metabolism
2025-03-04 | Journal article
DOI: 10.1186/s40170-025-00381-7
Part of ISSN: 2049-3002
Contributors: Lourdes Hontecillas-Prieto; Daniel J. García-Domínguez; Carlos Jiménez-Cortegana; Esteban Nogales-Fernández; Natalia Palazón-Carrión; Alejandro Martín García-Sancho; Eduardo Ríos-Herranz; Josep Gumà-Padrò; Mariano Provencio-Pulla; Antonio Rueda-Domínguez et al.
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Leptin and Leptin Signaling in Multiple Sclerosis: A Narrative Review

NeuroMolecular Medicine
2025-02-28 | Journal article
DOI: 10.1007/s12017-025-08842-4
Part of ISSN: 1559-1174
Contributors: Juan Antonio Flores-Cordero; Amalia Aranaz-Murillo; Teresa Vilariño-García; Antonio Pérez-Pérez; Guillermo Izquierdo; Rocío Flores-Campos; Lourdes Hontecillas-Prieto; Daniel J. García-Domínguez; Víctor Sánchez-Margalet
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Flow cytometry analysis of myeloid derived suppressor cells using 6 color labeling

Methods in Cell Biology
2024 | Book chapter
DOI: 10.1016/bs.mcb.2024.08.006
Part of ISBN: 9780443296161
Part of ISSN: 0091-679X
Contributors: Rocío Flores-Campos; Daniel J. García-Domínguez; Lourdes Hontecillas-Prieto; Carlos Jiménez-Cortegana; Luis de la Cruz-Merino; Víctor Sánchez-Margalet
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review)

International Journal of Oncology
2024-06-27 | Journal article
DOI: 10.3892/ijo.2024.5667
Part of ISSN: 1019-6439
Part of ISSN: 1791-2423
Contributors: Carlos Jiménez‑Cortegana; Cristian Gutiérrez‑García; Flora Sánchez‑Jiménez; Teresa Vilariño‑García; Rocio Flores‑Campos; Antonio Pérez‑Pérez; Carmen Garnacho; Maria Sánchez‑León; Daniel García‑Domínguez; Lourdes Hontecillas‑Prieto et al.
Source: Self-asserted source
Daniel J. Garcia-Dominguez

CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma

Frontiers in Immunology
2024-02-26 | Journal article
DOI: 10.3389/fimmu.2024.1293931
Part of ISSN: 1664-3224
Contributors: Lourdes Hontecillas-Prieto; Daniel J. García-Domínguez; Natalia Palazón-Carrión; Alejandro Martín García-Sancho; Esteban Nogales-Fernández; Carlos Jiménez-Cortegana; María L. Sánchez-León; Silvia Silva-Romeiro; Rocío Flores-Campos; Fernando Carnicero-González et al.
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer

International Journal of Molecular Sciences
2024-01 | Journal article | Author
DOI: 10.3390/ijms25021195
Contributors: Daniel J. Garcia-Dominguez; Soledad López-Enríquez; Gonzalo Alba Jiménez; Carmen Garnacho; Carlos Jiménez Cortegana; Rocío Flores-Campos; Luis de la Cruz-Merino; Nabil Hajji; Victor Sánchez-Margalet; Lourdes Hontecillas-Prieto
Source: check_circle
Multidisciplinary Digital Publishing Institute

Knowing the myeloid-derived suppressor cells: Another enemy of sarcomas patients

International Review of Cell and Molecular Biology
2023 | Book chapter
DOI: 10.1016/bs.ircmb.2022.11.003
Part of ISBN: 9780443191275
Part of ISSN: 1937-6448
Contributors: Daniel J. García-Domínguez; Víctor Sánchez-Margalet; Luis de la Cruz-Merino; Lourdes Hontecillas-Prieto
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells

International Journal of Molecular Sciences
2023-03 | Journal article | Author
DOI: 10.3390/ijms24065208
Contributors: María Luisa Sánchez-León; Carlos Jiménez Cortegana; Silvia Silva Romeiro; Carmen Garnacho; Luis de la Cruz-Merino; Daniel J. Garcia-Dominguez; Lourdes Hontecillas-Prieto; Victor Sánchez-Margalet
Source: check_circle
Multidisciplinary Digital Publishing Institute

Obesity and Risk for Lymphoma: Possible Role of Leptin

International Journal of Molecular Sciences
2022-12 | Journal article | Author
DOI: 10.3390/ijms232415530
Contributors: Carlos Jiménez Cortegana; Lourdes Hontecillas-Prieto; Daniel J. Garcia-Dominguez; Fernando Zapata; Natalia Palazón-Carrión; María L. Sánchez-León; Malika Tami; Antonio Pérez-Pérez; Flora Sánchez-Jiménez; Teresa Vilariño-García et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies

Cancers
2022-11 | Journal article | Author
DOI: 10.3390/cancers14215473
Contributors: Sara Sánchez-Molina; Elisabet Figuerola-Bou; Victor Sánchez-Margalet; Luis de la Cruz-Merino; Jaume Mora; Enrique de Alava; Daniel J. Garcia-Dominguez; Lourdes Hontecillas-Prieto
Source: check_circle
Multidisciplinary Digital Publishing Institute

Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma. Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis

Clinical Cancer Research
2022-07-18 | Journal article
DOI: 10.1158/1078-0432.ccr-22-0588
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics

Cancers
2022-03 | Journal article | Author
DOI: 10.3390/cancers14061469
Contributors: Daniel J. Garcia-Dominguez; Lourdes Hontecillas-Prieto; Natalia Palazón-Carrión; Carlos Jiménez Cortegana; Victor Sánchez-Margalet; Luis de la Cruz-Merino
Source: check_circle
Multidisciplinary Digital Publishing Institute

Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1.

Oncogene
2022-03-30 | Journal article | Author
DOI: 10.1038/s41388-022-02279-w
PMID: 35354905
PMC: PMC9054661
Contributors: Daniel J. Garcia-Dominguez; Nabil Hajji; López-Alemany R; Sara Sánchez-Molina; Elisabet Figuerola-Bou; Morón Civanto FJ; Santi Rello-Varona; Eduardo Andrés-León; Benito A; Keun HC et al.
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma

Oncogene
2021-08-03 | Journal article
DOI: 10.1038/s41388-021-01974-4
Part of ISSN: 0950-9232
Part of ISSN: 1476-5594
Source: Self-asserted source
Daniel J. Garcia-Dominguez

RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis

Science Advances
2020-10 | Journal article
DOI: 10.1126/sciadv.aba3058
Part of ISSN: 2375-2548
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials

Frontiers in Genetics
2020-09-11 | Journal article
DOI: 10.3389/fgene.2020.578011
Part of ISSN: 1664-8021
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution

Journal of Controlled Release
2020-08 | Journal article
DOI: 10.1016/j.jconrel.2020.05.032
Part of ISSN: 0168-3659
Source: Self-asserted source
Daniel J. Garcia-Dominguez

An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis

PLOS ONE
2020-06-05 | Journal article
DOI: 10.1371/journal.pone.0234243
Part of ISSN: 1932-6203
Source: Self-asserted source
Daniel J. Garcia-Dominguez

The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma

Oncotarget
2018-07-31 | Journal article
DOI: 10.18632/oncotarget.25829
Part of ISSN: 1949-2553
Source: Self-asserted source
Daniel J. Garcia-Dominguez

The bitter side of epigenetics: variability and resistance to chemotherapy

Epigenomics
2018-06-22 | Journal article
DOI: 10.2217/epi-2017-0112
Part of ISSN: 1750-1911
Part of ISSN: 1750-192X
Source: Self-asserted source
Daniel J. Garcia-Dominguez

HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients

2017 | Other
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.

2017-02 | Journal article
DOI: 10.18632/oncotarget.14491
PMID: 28061436
PMC: PMC5355255
Contributors: Hontecillas-Prieto L; Garcia-Dominguez DJ; Vaca DP; Garcia-Mejias R; Marcilla D; Ramirez-Villar GL; Saez C; de Álava E
Source: Self-asserted source
Daniel J. Garcia-Dominguez via Europe PubMed Central

RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein.

2016-07 | Journal article
DOI: 10.18632/oncotarget.10092
PMID: 27317769
Contributors: Hernandez-Muñoz I; Figuerola E; Sanchez-Molina S; Rodriguez E; Fernández-Mariño AI; Pardo-Pastor C; Bahamonde MI; Fernández-Fernández JM; García-Domínguez DJ; Hontecillas-Prieto L et al.
Source: Self-asserted source
Daniel J. Garcia-Dominguez via Europe PubMed Central

Innovative therapies in Ewing Sarcoma.

2014-01 | Journal article
DOI: 10.1097/PAP.0000000000000003
PMID: 24316910
Contributors: Amaral AT; Ordóñez JL; Otero-Motta AP; García-Domínguez DJ; Sevillano MV; de Álava E
Source: Self-asserted source
Daniel J. Garcia-Dominguez via Europe PubMed Central

WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells.

2013-03 | Journal article
DOI: 10.1038/onc.2012.153
PMID: 22641220
Contributors: Mackintosh C; García-Domínguez DJ; Ordóñez JL; Ginel-Picardo A; Smith PG; Sacristán MP; de Álava E
Source: Self-asserted source
Daniel J. Garcia-Dominguez via Europe PubMed Central

1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma.

2012-03 | Journal article
DOI: 10.1038/onc.2011.317
PMID: 21822310
Contributors: Mackintosh C; Ordóñez JL; García-Domínguez DJ; Sevillano V; Llombart-Bosch A; Szuhai K; Scotlandi K; Alberghini M; Sciot R; Sinnaeve F et al.
Source: Self-asserted source
Daniel J. Garcia-Dominguez via Europe PubMed Central

Methods of prognosticating and treating ewing sarcoma/pnet and other neoplasms

2011-12 | Other
Source: Self-asserted source
Daniel J. Garcia-Dominguez

Stabilization of Dll1 mRNA by Elavl1/HuR in neuroepithelial cells undergoing mitosis.

2011-04 | Journal article
DOI: 10.1091/mbc.E10-10-0808
PMID: 21346194
PMC: PMC3078063
Contributors: García-Domínguez DJ; Morello D; Cisneros E; Kontoyiannis DL; Frade JM
Source: Self-asserted source
Daniel J. Garcia-Dominguez via Europe PubMed Central

The clinical relevance of molecular genetics in soft tissue sarcomas.

2010-05 | Journal article
DOI: 10.1097/PAP.0b013e3181d98cbf
PMID: 20418671
Contributors: Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
Source: Self-asserted source
Daniel J. Garcia-Dominguez via Europe PubMed Central
How many people are using ORCID?